U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

SERENOA REPENS WHOLE

MORE DETAILS

487DXM62F2

structurally diverse
Status:
Possibly Marketed Outside US
Source:
SINGISO (0.8g) by Sae In Dang Co., Ltd.
(2016)
Source URL:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=36f2e13a-3609-582a-e054-00144ff88e88
First approved in 2016
Source:
SINGISO (0.8g) by Sae In Dang Co., Ltd.
Source URL:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=36f2e13a-3609-582a-e054-00144ff88e88
Class:
STRUCTURALLY DIVERSE
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966